Xometry (NASDAQ:XMTR – Get Free Report) had its price target hoisted by equities research analysts at JMP Securities from $34.00 to $42.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has a “market outperform” rating on the stock. JMP Securities’ target price would suggest a potential upside of 42.37% from the stock’s previous close.
Several other equities analysts also recently commented on XMTR. The Goldman Sachs Group raised their target price on Xometry from $24.00 to $28.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. UBS Group lifted their price objective on Xometry from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 6th. Royal Bank of Canada lifted their price objective on Xometry from $23.00 to $27.00 and gave the stock a “sector perform” rating in a research note on Wednesday, November 6th. Citigroup boosted their target price on Xometry from $25.00 to $33.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Finally, Cantor Fitzgerald reaffirmed an “underweight” rating and issued a $12.00 target price on shares of Xometry in a research note on Wednesday, November 6th. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Xometry currently has a consensus rating of “Hold” and a consensus price target of $27.71.
Read Our Latest Stock Report on XMTR
Xometry Stock Performance
Insider Buying and Selling at Xometry
In other Xometry news, Director Emily Rollins sold 3,729 shares of the firm’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $29.49, for a total transaction of $109,968.21. Following the completion of the sale, the director now owns 12,457 shares of the company’s stock, valued at $367,356.93. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, Director Emily Rollins sold 3,729 shares of the stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $29.49, for a total transaction of $109,968.21. Following the sale, the director now owns 12,457 shares in the company, valued at approximately $367,356.93. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CTO Matthew Leibel sold 3,400 shares of the business’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $18.45, for a total value of $62,730.00. Following the transaction, the chief technology officer now directly owns 82,918 shares of the company’s stock, valued at approximately $1,529,837.10. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 41,633 shares of company stock worth $1,201,730. Insiders own 16.79% of the company’s stock.
Hedge Funds Weigh In On Xometry
Several large investors have recently modified their holdings of XMTR. State Board of Administration of Florida Retirement System increased its stake in shares of Xometry by 22.1% in the first quarter. State Board of Administration of Florida Retirement System now owns 11,840 shares of the company’s stock valued at $200,000 after buying an additional 2,140 shares during the period. Vanguard Group Inc. lifted its position in shares of Xometry by 2.0% in the 1st quarter. Vanguard Group Inc. now owns 3,877,346 shares of the company’s stock worth $65,488,000 after purchasing an additional 76,976 shares during the period. Texas Capital Bank Wealth Management Services Inc bought a new stake in shares of Xometry in the 1st quarter valued at $169,000. Clearbridge Investments LLC increased its position in shares of Xometry by 20.7% during the first quarter. Clearbridge Investments LLC now owns 1,270,631 shares of the company’s stock worth $21,461,000 after buying an additional 217,939 shares during the period. Finally, Sylebra Capital LLC raised its stake in Xometry by 1,005.3% during the first quarter. Sylebra Capital LLC now owns 644,262 shares of the company’s stock worth $10,882,000 after buying an additional 585,971 shares during the last quarter. Institutional investors own 97.31% of the company’s stock.
About Xometry
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Featured Articles
- Five stocks we like better than Xometry
- Insider Trading – What You Need to Know
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- How to Capture the Benefits of Dividend Increases
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.